I would have paid to be eating at this table: WR Hambrecht analyst (and professional Exubera/Pfizer-hater) Andrew Forman had dinner with the founder of Nektar (John Patton?) at the ADA industry confab, Forman revealed in note to investors today.
Regular BWNRX readers will know that Forman has devoted many electronic words to insulting the "Nektarines" and Exubera, the disastrous diabetes brand that the company managed to sell to Pfizer (If you click that link, work your way backwards through the posts for the full Forman vs. Nektar soap opera).
Here's his account:
"Investors rewarded the one-year anniversary of Exubera's coming out party (diabetics will have until the end of this year for the anniversary of actual product availability) by pushing NKTR stock to a new low which based on our previous sum of the parts analysis that NKTR is worth $10 to $12 ex-Exubera implies that this pioneering breakthrough that consumed well over $2B and 15 years before the launch is worth less than worthless. Dinner with the founder who was sporting the new second generation monthly disposable prototype that will be easier to use demonstrated that the continuous improvement inhaled insulin lifecycle strategy remains on track. But the problem, as many may have discerned while waltzing through the competitive landscape of diabetes purveyors this weekend, lies squarely at the marketing door of Pfizer who is still learning diabetes disease management is complex and lack of marketing insulin experience has yet to connect with the many thousands of potential Exubera prescribers."
But the food was fantastic, I'm sure.

A little bird tells me that Pfizer were all over the Diabetology biotech company and their oral insulin.
Whilst at he same time they were promoting the bong in the exhibition hall!
Posted by: Jack Friday | June 26, 2007 at 06:22 PM
Its so important to know how to construct a great blog to get people interested and you’ve done just that. . Waiting your next wonderfull posting.
Posted by: coach suitcase | July 02, 2010 at 12:14 AM